Navigation Links
Benchmark Research Honored With Industry Accolades
Date:4/26/2013

Austin, Texas (PRWEB) April 26, 2013

Benchmark Research is honored to be recognized by two industry leading professional organizations, the Association of Clinical Research Professionals (ACRP) and the World Vaccine Congress (WVC), at their annual conferences last week.

ACRP awarded the 2013 Outstanding Leadership in Clinical Research Award for Leadership as a CRC to Benchmark’s Ann Rutledge, MA, CCRC, during their annual Global Conference & Exhibition in Orlando, Fla. on April 14. The award recognizes individuals who have made exceptional leadership/practice contributions that have furthered the vision and mission of ACRP.

Based at Benchmark’s Austin clinical research site, Ann is both Manager of Quality Control and a Senior Clinical Research Coordinator. She is recognized for her extensive experience developing and implementing site processes and standard operating procedures, as well as for creating and presenting training internally and for ACRP. “Being acknowledged for a focus on continuous quality improvement is very rewarding,” said Ann, who has more than 16 years of experience in clinical research and 26 years in the medical field. A Certified CRC since 2002, Ann was the founding chapter chair for the ACRP Central Texas Chapter.

The WVC recognized Benchmark’s Fort Worth site, part of VaxNet/Vax Consortium, as “Highly Recommended” and runner-up in the Best Clinical Site & Trial Network category at the Sixth Annual Vaccine Industry Excellence (ViE) Awards presented on April 17 in Washington, D.C. The only awards ceremony dedicated to the vaccine industry, the ViE Awards honor individuals, organizations and initiatives which have made significant contributions over the past 12 months.

Last year Benchmark’s Austin site took home the 2012 ViE award in the Best Clinical Trial Site category, while VaxNet was Highly Recommended and runner-up for the then-separate Best Site Network category. “We are honored to be recognized again for our commitment to excellence in vaccine research,” said Mark Lacy, founder and CEO of Benchmark Research. “Both the ACRP award to Ann and the ViE awards to our sites underscore the priority Benchmark places on raising the standard in clinical research.”

Read the full story at http://www.prweb.com/releases/2013/4/prweb10667632.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013
2. PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative Biotechs
3. ISPE Conference to Benchmark and Advance Quality by Design in the Biopharmaceutical Industry
4. iLab Solutions Conducts Its Third Annual Core Facility Benchmarking Study
5. SPIE Smart Structures/NDE Researchers Look to Nature for Inspiration
6. South Dakota School of Mines & Technology Researchers Document Splitting Water Molecules in Multiple Thermochemical Cycles with Goal to Sustain Hydrogen Energy
7. Research Foundations Collaborate To Fund Phase 1 Study Of Cancer Drug In Alzheimers Disease Patients
8. Crystal Research Associates, LLC Issues Quarterly Update on MetaStat, Inc.
9. Spaulding Clinical Research Partners With Verified Clinical Trials Protecting Clinical Trials From Dual Enrollment
10. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
11. Medrio, a Leading EDC and eClinical SaaS Provider for Clinical Research, Announces the Highly Anticipated Release of Medrio 8.1 with iPad Support
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):